The US dollar traded near its weakest level in almost four years as of writing, extending losses for a fourth straight session. The Bloomberg Dollar Spot Index The US dollar traded near its weakest level in almost four years as of writing, extending losses for a fourth straight session. The Bloomberg Dollar Spot Index

US Dollar Slides to Lowest Level in Four Years as Policy and Fed Risks Mount

2026/01/28 04:02
3 min read

The US dollar traded near its weakest level in almost four years as of writing, extending losses for a fourth straight session. The Bloomberg Dollar Spot Index fell as much as 0.7% to its lowest level since March 2022, placing the greenback on track for its worst stretch since President Donald Trump announced universal tariffs last April.

Currency markets reacted swiftly, with investors reassessing the dollar’s role amid rising political and policy risks.

Policy Uncertainty Weighs on the Greenback

The dollar’s slide reflects growing caution around Washington’s policy direction. Market participants pointed to unpredictable decision-making, including renewed geopolitical rhetoric and concerns about US trade and security commitments. Over a longer horizon, fears around Federal Reserve independence, an expanding budget deficit, and fiscal credibility have steadily eroded confidence in the currency.

Source: Bloomberg via X

Strategists highlighted that structural pressures now dominate the narrative. Analysts at Brown Brothers Harriman noted that fading trust in US governance and politicization of monetary policy could outweigh near-term economic resilience. As these risks accumulated, investors trimmed dollar positions despite stable domestic data.

Global Currencies Gain Momentum

As the dollar weakened, major currencies strengthened sharply. The euro climbed to around $1.1972, its strongest level since 2021, while the British pound rose to near $1.3791, also a multi-year high. The Japanese yen advanced about 0.7% to roughly 153.03 per dollar, supported by signals of potential intervention from Japanese authorities.

The Swiss franc also gained ground, appreciating to levels last seen in 2015. Emerging-market currencies joined the rally, with most developing-market FX tracked by Bloomberg advancing against the dollar. An index measuring these currencies, including interest returns, reached a record high as the greenback retreated.

Intervention Signals Add Pressure

Currency markets reacted strongly to signs of official scrutiny over yen movements. Reports indicated that the Federal Reserve Bank of New York contacted financial institutions to review the dollar-yen exchange rate, a step often associated with intervention preparation. Japanese officials later confirmed close coordination with US authorities if sharp currency moves persisted.

Traders described the rate checks as a catalyst that deepened dollar losses. Talk of coordinated action revived speculation about efforts to guide the greenback lower against key trading partners, reinforcing bearish sentiment.

Fed Outlook Shapes Dollar Expectations

The dollar’s weakness unfolded ahead of the January 28th Federal Open Market Committee meeting. The Fed begins deliberations today, with markets pricing a 97.2% probability of no rate change. The previous and forecast federal funds rates both stand at 3.75%, signaling broad agreement around a pause.

Source: Forex Factory

Recent US data showed official CPI inflation holding at 2.7% and PCE inflation edging up to 2.8%, while labor indicators surprised to the upside. These readings gave policymakers room to delay further easing, especially as prior data faced distortion from the 2025 government shutdown. Even so, independent inflation measures pointed to sharp cooling in January, adding complexity to expectations.

December Decision Still Reverberates

The Fed’s December meeting delivered a 25-basis-point cut, lowering the federal funds rate to a 3.50%–3.75% range. That decision marked the third cut of the year and revealed internal divisions, with two members favoring a hold and Governor Miran backing a deeper cut. The mixed signal continues to influence dollar sentiment.

With Jerome Powell heading into one of his final meetings as chair, markets remain alert. Any shift in tone could move currencies quickly. For now, a steady Fed stance combined with political uncertainty leaves the dollar under sustained pressure.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26